Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

[1] Mannino DM(2007)Global burden of COPD: risk factors, prevalence, and future trends Lancet 370 765-773

[2] Buist AS(2008)Formoterol in the management of chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis. 3 205-215

[3] Steiropoulos P(2013)Long-term macrolide treatment for chronic respiratory disease Eur Respir J 42 239-251

[4] Tzouvelekis A(2012)Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality Thorax 67 957-963

[5] Bouros D(2011)Exacerbation phenotyping in chronic obstructive pulmonary disease Am J Respir Crit Care Med 184 625-626

[6] Spagnolo P(2008)Infection in the pathogenesis and course of chronic obstructive pulmonary disease N Engl J Med 359 2355-2365

[7] Fabbri LM(2006)Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD J Gen Intern Med 21 1011-1019

[8] Bush A(2015)Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter? Curr Opin Pulm Med 21 142-148

[9] Suissa S(2015)Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation Ann Intensive Care 5 30-124

[10] Dell’Aniello S(2012)Antibiotics for exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst Rev 12 CD010257-229

[1] Mannino DM(2007)Global burden of COPD: risk factors, prevalence, and future trends Lancet 370 765-773

[2] Buist AS(2008)Formoterol in the management of chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis. 3 205-215

[3] Steiropoulos P(2013)Long-term macrolide treatment for chronic respiratory disease Eur Respir J 42 239-251

[4] Tzouvelekis A(2012)Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality Thorax 67 957-963

[5] Bouros D(2011)Exacerbation phenotyping in chronic obstructive pulmonary disease Am J Respir Crit Care Med 184 625-626

[6] Spagnolo P(2008)Infection in the pathogenesis and course of chronic obstructive pulmonary disease N Engl J Med 359 2355-2365

[7] Fabbri LM(2006)Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD J Gen Intern Med 21 1011-1019

[8] Bush A(2015)Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter? Curr Opin Pulm Med 21 142-148

[9] Suissa S(2015)Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation Ann Intensive Care 5 30-124

[10] Dell’Aniello S(2012)Antibiotics for exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst Rev 12 CD010257-229